Related Experiment Videos
Changes in drug sensitivity following acute and chronic exercise.
Pharmacology, Biochemistry, and Behavior
|August 1, 1985
Summary
Exercise impacts drug sensitivity. Acute exercise increases sensitivity to muscarinic antagonists, but chronic exercise and fitness level may alter this drug response.
Area of Science:
- Pharmacology
- Exercise Physiology
- Neuroscience
Background:
- Drug sensitivity is influenced by various biological and environmental factors.
- Factors like genetics, age, and sleep deprivation can alter drug responses.
- Chronic drug administration can lead to tolerance, acting as a biological variable, while acute administration acts as an environmental variable.
Purpose of the Study:
- To investigate the role of exercise as both a biological and environmental variable affecting drug sensitivity.
- To determine how chronic exercise (biological variable) and acute exercise (environmental variable) influence responses to muscarinic antagonists.
- To understand if physical fitness level modifies the effects of exercise on drug sensitivity.
Main Methods:
- The study compared drug sensitivity in physically conditioned animals versus non-exercised controls.
- Animals were tested under both rested conditions and after mild acute exercise.
- Sensitivity to muscarinic antagonists was measured in different exercise states.
Main Results:
- Physical fitness level, resulting from chronic exercise, did not significantly alter drug sensitivity in rested subjects.
- Mild acute exercise increased sensitivity to muscarinic antagonists in control (non-exercised) subjects.
- Exercise-trained animals did not show increased sensitivity to muscarinic antagonists following acute exercise.
Conclusions:
- Exercise state should be recognized as an environmental variable that can modify drug responses.
- Biological fitness, achieved through chronic exercise, can modulate the impact of acute exercise on drug sensitivity.
- These findings highlight the complex interplay between exercise, fitness, and pharmacological outcomes.